Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 320017 · LSTA

Lisata Therapeutics, Inc.

Filing with the SEC SEC-reporting company Basking Ridge, NJ Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • RestructuringOn Aug 4, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
  • Several leadership changes4 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $17M for the year (2024: −$20M).
  • Revenue downRevenue fell from $1M in 2024 to $170K in 2025 (83% lower).
  • Private capital raiseOn Oct 2, 2026 the company filed Form D: $352M offered · $352M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$170K$1M
Net income (loss)−$17M−$20M
Total assets$17.7M$35M
Total liabilities$3.1M$5.7M
Stockholders’ equity$14.9M$29.6M
Cash and equivalents$16M$16.2M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
LISATA THERAPEUTICS, INC.
Formerly: Caladrius Biosciences, Inc.
CIK
0000320017
Tickers
LSTA
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Legal form
Corporation
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Basking Ridge, New Jersey
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Latest exempt offering
$352M offered · $352M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 8.01, 9.01 · filed Nov 9, 2026 · filing
  • Director or officer change: CFO change
    Form 8-K · items 5.02, 9.01 · filed Oct 14, 2026 · filing
  • Private raise (Form D): $352M offered · $352M sold · Biotechnology
    Form D · items 06B · filed Oct 2, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Sep 17, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Sep 17, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.05, 5.02, 8.01, 9.01 · filed Aug 4, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 5.02, 8.01, 9.01 · filed Aug 4, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 11, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 12, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 7, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Jun 17, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jun 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 27, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 27, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02 · filed Jun 27, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 17, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 29, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 29, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 2, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 11, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 9, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 9, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 1, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 30, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 30, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Feb 6, 2023 · filing